(Q42047623)

English

Ole Isacson: development of new therapies for Parkinson's disease (interview).

scientific article

Ole Isacson: Development of New Therapies for Parkinson's Disease

In more languages

default values for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

15 October 2017

Ole Isacson: development of new therapies for Parkinson's disease (interview). (English)

1 reference

stated in

Europe PubMed Central

15 October 2017

1 reference

0 references

Ole Isacson

1

1 reference

stated in

ORCID Public Data File 2021

publication date

29 April 2007

1 reference

stated in

Europe PubMed Central

15 October 2017

Journal of Visualized Experiments

1 reference

stated in

Europe PubMed Central

15 October 2017

3

1 reference

stated in

Europe PubMed Central

15 October 2017

189

1 reference

stated in

Europe PubMed Central

15 October 2017

Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2535843

retrieved

5 June 2018

Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2535843

retrieved

5 June 2018

Intrastriatal transforming growth factor alpha delivery to a model of Parkinson's disease induces proliferation and migration of endogenous adult neural progenitor cells without differentiation into dopaminergic neurons

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2535843

retrieved

5 June 2018

Selective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson's disease

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2535843

retrieved

5 June 2018

The production and use of cells as therapeutic agents in neurodegenerative diseases

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2535843

retrieved

5 June 2018

Identifiers

DOI

10.3791/189

1 reference

stated in

Europe PubMed Central

15 October 2017

1 reference

Europe PubMed Central

PMC publication ID

2535843

retrieved

15 October 2017

PubMed publication ID

18978995

1 reference

stated in

Europe PubMed Central

PMC publication ID

2535843

retrieved

15 October 2017

ResearchGate publication ID

23446417

0 references

(Q42047623)

Ole Isacson: development of new therapies for Parkinson's disease (interview).

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)